Elife Holdings Limited (ELIFE HLDGS) filed its monthly return for the period ended 31 May 2026, confirming no changes to either authorised or issued share capital while detailing the first grant under its newly-adopted share option scheme.

Authorised and Issued Share Capital • Authorised share capital stood unchanged at 3.00 billion ordinary shares with a par value of HKD 0.10 each, equivalent to HKD 300.00 million. • Issued share capital remained at 1.63 billion shares, representing a 54.25% utilisation of the authorised limit. • The company held no treasury shares, and there were no share repurchases or cancellations during the month.

Public Float Compliance • Elife confirmed that it met the Main Board’s minimum 25% public-float requirement as at 31 May 2026.

Share Option Activity • Under the “New Share Scheme” approved on 6 March 2026, the company granted 85.50 million share options in May. • All 85.50 million options remained outstanding at month-end; no shares were issued or treasury shares transferred pursuant to option exercises. • These outstanding options represent potential dilution of approximately 5.25% of the current issued share base. • The scheme still allows for up to 135.62 million shares to be issued or transferred on full exercise of all options that may be granted, implying a maximum potential dilution of about 8.34%.

Other Equity Instruments • The company reported no warrants, convertible securities, other share-issue agreements, or movements in treasury shares for the month.

Compliance Statement • The filing confirms all regulatory, listing-rule and legal requirements were met for the reported period.

With stable share capital and the initiation of its 2026 share option programme, Elife Hldgs maintains capacity for further equity issuance while preserving compliance with Hong Kong’s public-float rules.